Literature DB >> 11286851

Methodologies and tools for proton beam design for lung tumors.

M F Moyers1, D W Miller, D A Bush, J D Slater.   

Abstract

PURPOSE: Proton beams can potentially increase the dose delivered to lung tumors without increasing the dose to critical normal tissues because protons can be stopped before encountering the normal tissues. This potential can only be realized if tissue motion and planning uncertainties are correctly included during planning. This study evaluated several planning strategies to determine which method best provides adequate tumor coverage, minimal normal tissue irradiation, and simplicity of use. METHODS AND MATERIALS: Proton beam treatment plans were generated using one or more of three different planning strategies. These strategies included designing apertures and boluses to the PTV, apertures to the PTV and boluses to the CTV, and aperture and bolus to the CTV.
RESULTS: The planning target volume as specified in ICRU Report 50 can be used only to design the lateral margins of beams, because the distal and proximal margins resulting from CT number uncertainty, beam range uncertainty, tissue motions, and setup uncertainties, are different than the lateral margins resulting from these same factors. The best strategy for target coverage with the planning tools available overirradiated some normal tissues unnecessarily. The available tools also made the planning of lung tumors difficult.
CONCLUSIONS: This study demonstrated that inclusion of target motion and setup uncertainties into a plan should be performed in the beam design step instead of creating new targets. New computerized treatment planning system tools suggested by this study will ease planning, facilitate abandonment of the PTV concept, improve conformance of the dose distribution to the target, and improve conformal avoidance of critical normal tissues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286851     DOI: 10.1016/s0360-3016(00)01555-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  90 in total

1.  Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer.

Authors:  Arya Amini; Katherine Ciura; James Welsh; Ngoc Nguyen; Matt Palmer; Pamela K Allen; Michael Paolini; Zhongxing Liao; Jaques Bluett; Radhe Mohan; Daniel Gomez; James D Cox; Ritsuko Komaki; Joe Y Chang
Journal:  Med Dosim       Date:  2013       Impact factor: 1.482

Review 2.  Radiation techniques in neuro-oncology.

Authors:  Deepak Khuntia; Wolfgang A Tomé; Minesh P Mehta
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 3.  Robustness Analysis for External Beam Radiation Therapy Treatment Plans: Describing Uncertainty Scenarios and Reporting Their Dosimetric Consequences.

Authors:  Adam D Yock; Radhe Mohan; Stella Flampouri; Walter Bosch; Paige A Taylor; David Gladstone; Siyong Kim; Jason Sohn; Robert Wallace; Ying Xiao; Jeff Buchsbaum
Journal:  Pract Radiat Oncol       Date:  2018-12-15

4.  Does kV-MV dual-energy computed tomography have an advantage in determining proton stopping power ratios in patients?

Authors:  M Yang; G Virshup; J Clayton; X R Zhu; R Mohan; L Dong
Journal:  Phys Med Biol       Date:  2011-06-30       Impact factor: 3.609

5.  Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer.

Authors:  Laura A Rechner; Rebecca M Howell; Rui Zhang; Carol Etzel; Andrew K Lee; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2012-10-10       Impact factor: 3.609

6.  A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties.

Authors:  Peter C Park; X Ronald Zhu; Andrew K Lee; Narayan Sahoo; Adam D Melancon; Lifei Zhang; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-22       Impact factor: 7.038

7.  A Technical Guide for Passive Scattering Proton Radiation Therapy for Breast Cancer.

Authors:  Julie A Bradley; Meng Wei Ho; Zuofeng Li; Xiaoying Liang; Michael Rutenberg; Roi Dagan; Nancy P Mendenhall
Journal:  Int J Part Ther       Date:  2017-07-11

8.  Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.

Authors:  Chenbin Liu; Steven E Schild; Joe Y Chang; Zhongxing Liao; Shawn Korte; Jiajian Shen; Xiaoning Ding; Yanle Hu; Yixiu Kang; Sameer R Keole; Terence T Sio; William W Wong; Narayan Sahoo; Martin Bues; Wei Liu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-02-14       Impact factor: 7.038

9.  Risk-optimized proton therapy to minimize radiogenic second cancers.

Authors:  Laura A Rechner; John G Eley; Rebecca M Howell; Rui Zhang; Dragan Mirkovic; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2015-04-28       Impact factor: 3.609

10.  Impact of margin size on the predicted risk of radiogenic second cancers following proton arc therapy and volumetric modulated arc therapy for prostate cancer.

Authors:  Laura A Rechner; Rebecca M Howell; Rui Zhang; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2012-11-15       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.